Products

Calibrate
Calibrate
Endocrinology & Metabolic AI
Calibrate is a metabolic health platform offering GLP-1 medication, coaching, and monitoring for sustainable weight loss.

See all 1 product →

About Calibrate

Calibrate is a digital metabolic health company that offers a one-year program focused on sustainable weight loss and improved metabolic health. The program integrates FDA-approved GLP-1 medications with a holistic approach that includes one-on-one virtual doctor visits and personalized coaching on four pillars: food, sleep, exercise, and emotional health. The company emphasizes a clinician-guided, value-based outcomes model, aiming to drive long-term results and reduce overall healthcare costs for employers and payers. Calibrate’s approach is designed to create enduring healthy habits and support physiological changes, with members typically seeing improvements in metabolic markers beyond just weight loss, such as HbA1c, insulin levels, LDL cholesterol, triglycerides, and liver health.

For physicians, Calibrate provides a structured program that combines pharmacotherapy with intensive lifestyle intervention. The platform offers real-time visibility into member data for clinicians and coaches, facilitating consistent and accountable care. Calibrate’s medical team consists of obesity-certified clinicians licensed across multiple states and board-certified in various specialties, including Obesity Medicine, Lifestyle Medicine, and Endocrinology. The program requires members to undergo lab tests, have virtual clinical visits, and engage in bi-weekly coaching sessions and curriculum lessons. Calibrate aims to address the root causes of metabolic dysfunction and has transitioned to an enterprise-focused solution, partnering with employers and health plans to manage the rising demand for GLP-1 medications and ensure sustainable outcomes.

Calibrate’s program has demonstrated an average body weight loss of 14% in its first cohort and 18.2% sustained over two years for members. The company highlights its commitment to publishing results and setting a new standard of care for obesity treatment. Calibrate’s model is built to ensure prescribing clinicians and coaches work together on a single platform, integrating GLP-1 treatment with comprehensive behavior change management to optimize clinical value and manage pharmacy trends.

Focus Areas

Metabolic health sustainable weight loss obesity management GLP-1 medication integration personalized coaching behavior change (food sleep exercise emotional health) telehealth employer and health plan partnerships.

Business Intelligence

Key InvestorsFounders Fund, Tiger Global Management, Optum Ventures, Forerunner Ventures, Threshold Ventures, Redesign Health, Madryn Asset Management
PartnershipsOptumRx, FedEx, AdFarm, Petersen & Company
Acquisitionsunknown
Technologydigital metabolic health platform, proprietary pharmacy engine, AI-powered tools for clinical calibration and training (for a different "Calibrate" company in dentistry)
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

Metabolic Health & Sustainable Weight Loss
Calibrate offers a year-long Metabolic Reset program that combines GLP-1 medication with a structured curriculum focusing on four pillars: food, sleep, exercise, and emotional health. This approach aims to address the underlying biology of weight loss and promote sustainable behavior change.
GLP-1 Medication Integration
Calibrate integrates FDA-approved GLP-1 receptor agonists (such as Wegovy, Ozempic, Mounjaro, Rybelsus, Trulicity, and Saxenda) into its program. These medications help regulate appetite, improve glucose control, and support long-term weight loss, working in conjunction with lifestyle changes.
Personalized Coaching & Behavior Change
The program includes biweekly, one-on-one virtual coaching sessions and a curriculum designed to instill lasting behavior changes in food habits, physical activity, sleep quality, and emotional health.
Telehealth Model
Calibrate's program is entirely virtual, providing access to clinicians and coaching sessions via video calls and an in-app communication system. This allows members to access care from various locations.
Employer and Health Plan Partnerships
Calibrate has transitioned to an enterprise-focused solution, partnering with employers and health plans to offer its obesity management program. They aim to manage GLP-1 costs and improve outcomes for employee populations, demonstrating significant ROI and cost savings.
Physician Tip

For physicians, Calibrate offers a comprehensive, evidence-based approach to obesity management that combines medication with intensive lifestyle intervention. The program's focus on metabolic health, sustained weight loss (averaging 16% in the first year and up to 21% by year four), and improvement in cardiometabolic biomarkers (e.g., normalizing HbA1c, insulin, and liver enzymes) can be particularly appealing. Calibrate's model includes board-certified clinicians who oversee medication management and work in conjunction with primary care providers. The emphasis on behavior change alongside GLP-1s aims for long-term sustainability, even after medication tapering. Physicians can be confident in a program that provides structured accountability, digital tracking tools, and a curriculum covering food, sleep, exercise, and emotional health. Calibrate also provides real-world data on outcomes across diverse populations, which can be valuable for understanding program effectiveness.

Calibrate's platform provides real-time visibility into member data for both clinicians and coaches, ensuring coordinated care. While specific details of their technology stack for patient-facing applications are not extensively publicized, their operational infrastructure for internal processes includes tools like Dubsado for client management, Asana for project management, Slack for communication, Acuity Scheduling, and Google Workspace. The company emphasizes a 'People Operating System' approach to define role expectations, build competence, ensure compliance, and provide leaders with real-time visibility across teams. They also leverage an app for progress tracking. Calibrate's model supports seamless integration with pharmacy benefit managers (PBMs) for medication optimization and cost control.

Products by Calibrate

1 product in the directory

Calibrate
Calibrate
Endocrinology & Metabolic AI
Calibrate is a metabolic health platform offering GLP-1 medication, coaching, and monitoring for sustainable weight loss.

What the Web Says

Calibrate is a metabolic health company focused on weight loss through a program combining GLP-1 medication with lifestyle changes (food, sleep, exercise, and emotional health). While many members report significant weight loss and appreciate the coaching and curriculum, there are widespread complaints about poor communication, disorganization, and difficulties with medication access and insurance approvals. The company has also faced criticism regarding its work environment and high employee turnover.

Overall: Mixed

Strengths

  • Effective for weight loss and sustained results for many users.
  • Comprehensive program covering four pillars of metabolic health (food, sleep, exercise, emotional health).
  • Supportive coaching and curriculum.
  • Helps some users get insurance coverage for medication.
  • Focus on biology over willpower.

Limitations

  • Frequent issues with communication and disorganization.
  • Difficulties with medication access and insurance approvals.
  • Poor customer service and long response times.
  • High employee turnover and a toxic work environment reported by some.
  • App usability issues.
  • High cost of the program in addition to medication.

Based on reviews from: Reddit, Indeed.com, joincalibrate.com, Capterra, TrustPilot

Last updated: 2026-07-27

Videos

News, demos, and interviews about Calibrate.

Loading videos...

Videos load interactively. If none appear, search YouTube for Calibrate →

View all on YouTube

Press & Coverage

PR Newswire
Calibrate Publishes Largest Real-World Four-Year Analysis of GLP-1 Weight Loss Outcomes When Paired with Integrated Behavioral Support
Calibrate released its 2026 Results Report, showcasing a four-year analysis of over 50,000 members demonstrating sustained weight loss and cardiometabolic improvement through their integrated clinical and coaching solution for obesity care. The analysis shows members on GLP-1s lose, on average, 16% of their body weight in the first year, 18% by year two, 20% by year three, and 21% by year four.
2026-05
PR Newswire
Calibrate Completes Transition to Enterprise-Focused Obesity Management, More Than Doubles Client Roster
Calibrate announced its successful transition from a direct-to-consumer model to an enterprise-focused solution for obesity management, serving employers, health plans, and channel partners. This shift has resulted in profitability for the first time in the company's history and a significant expansion of its client base.
2026-02
Calibrate
Calibrate Unveils Fourth Annual Results Report
Calibrate's fourth annual Results Report highlights 19% average sustained weight loss at 36 months for members in its Metabolic Reset program, which integrates GLP-1 medications with Intensive Lifestyle Intervention. The report also notes significant improvements in metabolic markers and waist circumference.
2025-01
Calibrate
Transforming Workplace Health: Calibrate Results Demonstrate the Significance of a BMI of <25
Calibrate presented new research at Obesity Week 2024, showing how its program helps members achieve a healthy BMI of less than 25, which is crucial for reducing metabolic health risks. The program aims to enhance individual health and drive improvements in organizational productivity and healthcare cost reduction.
2024-11
Calibrate
Unlocking the Future of Weight Loss: Insights from Rob MacNaughton, Calibrate CEO
Calibrate CEO Rob MacNaughton discussed the company's integrated model, combining GLP-1 receptor agonists with structured behavior modification, which has led to an average weight loss of 16% in the first year and 18% by the end of the second year for 16,000 members. He emphasized the importance of combining medication with lifestyle interventions for sustained results.
2024-10
Calibrate
Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment
Calibrate presented research at the 2024 Endocrine Society meeting, analyzing outcomes from over 7,600 members, showing an average weight loss of 16.2% at 12 months and 17.2% at 24 months. The study highlighted the program's effectiveness even with GLP-1 medication access challenges.
2024-08
Business Wire
Calibrate Sets New Benchmark in Obesity Treatment: Demonstrates a Remarkable 18% Sustained Weight Loss for Members at 24 Months, Outperforming GLP-1 Medication Trials
Calibrate announced groundbreaking results from its largest real-world member cohort, with program-wide weight loss surpassing outcomes observed in GLP-1 medication clinical trials, showing 16.2% average weight loss at 12 months and 17.9% at 24 months.
2024-01
Signalbase
Calibrate Secures $100M in Series B Funding to Revolutionize Weight Treatment
Calibrate successfully raised $100 million in Series B funding to expand its clinician-guided and value-based obesity treatment program, which integrates medication with behavioral change to improve metabolic health and reduce healthcare costs.
2024-09

Frequently Asked Questions

Calibrate focuses on a 'Whole-Person Approach' to metabolic health, combining GLP-1 medication with intensive lifestyle intervention. This differs from traditional programs by integrating evidence-based pharmacotherapy with personalized coaching on food, sleep, exercise, and emotional health, aiming for sustainable weight loss and improved metabolic markers rather than just temporary solutions.
Calibrate integrates GLP-1 medications as a key component of its program, prescribed by Calibrate doctors after a thorough medical evaluation to determine patient eligibility. The protocol includes an initial consultation, ongoing virtual check-ins, and continuous monitoring of patient progress and medication efficacy and tolerability, with adjustments made as needed.
Calibrate provides personalized coaching through a team of credentialed coaches who guide members on sustainable behavior change across food, sleep, exercise, and emotional health. Compliance and long-term engagement are fostered through a structured curriculum, regular check-ins, goal setting, and a supportive community, all delivered via a convenient telehealth platform.
Calibrate's telehealth model delivers care virtually, with a medical team comprised of board-certified doctors and credentialed coaches. High-quality care and patient safety are ensured through evidence-based protocols, continuous training for staff, secure data management, and a focus on patient-reported outcomes and regular clinical oversight.
Calibrate partners with employers and health plans to offer its metabolic health program as a covered benefit. Benefits for these organizations include improved employee health outcomes, reduced healthcare costs associated with obesity and related comorbidities, increased productivity, and enhanced employee satisfaction and retention.
Calibrate's pricing structure typically involves an annual program fee, which may or may not include the cost of medication. Calibrate actively works with major health plans to secure insurance coverage for both the program and GLP-1 medications, and also offers financing options to make the program more accessible to a wider range of patients.
Calibrate measures program success through various metrics, including average weight loss, improvements in metabolic markers (e.g., A1C, blood pressure), and sustained behavior change. They regularly publish outcomes data, demonstrating significant and sustained weight loss for members, along with improvements in overall health and well-being.

Investors

Who's funded Calibrate.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.